Decided on additional surgery to remove any remaining lymph nodes and fatty tissue that Dr. Lucci (Surgical Oncologist at MD Anderson) sees necessary. Leaving today for MD Anderson...4/6 is MRI of brain, 4/7 pre-op, 4/8 surgery.
Blood work returned a different DNA type than what's required for the proposed clinical trial. Traditional Intron A therapy is the only current option. After recovering from surgery and finding out if there were additional positive nodes we will give Intron A final consideration. When weighing the risks and side effects it is very hard to see the benefit. The drug company quotes statistics from the FDA trial that approved the drug as having 66% of patients suffering adverse reactions, 14% suffering life threatening reactions, and 96% as having severe fatigue. The benefits are quoted as reducing the likeliness of recurrence by 10%.
Harvey & Erica Braden
Journal of our journey with a Metastatic Melanoma Diagnosis. Erica was diagnosed Stage 3 in January 2010 and then Stage 4 in April 2018.